1 Min Read
NEW YORK, Jan 11 (Reuters) - ArQule Inc : * Shares down 20 percent in premarket trade on news experimental cancer drug
fails mid-stage study
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.